Skip to main content
. 2018 Jan-Feb;63(1):22–29. doi: 10.4103/ijd.IJD_581_17

Figure 1.

Figure 1

The first phase of the pathogenesis of AGEP; activation and expansion of drug-specific T-cells with subsequent migration to the skin. APC: antigen presenting cells. IL: interleukin; MHC: major histocompatibility complex